SD Biosensor Signs Tripartite MOU for R&D of New Products for Extensively Drug-Resistant Tuberculosis with Japan’s RIT/JATA and Korea’s International Tuberculosis Research Center
SD Biosensor strengthens its new product lineup with the POC molecular diagnostic platform M10 Early detection of patients is expected to contribute to the eradication of tuberculosis in high-risk Asian countries SEOUL, South Korea, Dec. 6, 2024 /PRNewswire/ -- SD Biosensor, Inc. (KQ137310), South Korea's global in-vitro diagnostics company, announced the signing of a tripartite memorandum of understanding...
Alamar Biosciences Establishes Commercial Presence in APAC Region with First ARGO HT Install at Hong Kong Center for Neurodegenerative Diseases
FREMONT, Calif., Dec. 6, 2024 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce its commercial presence in the Asia Pacific (APAC) region with the installation of the ARGO™ HT System, an advanced ultra-sensitive proteomics platform, at the prestigious Hong Kong Center for Neurodegenerative Diseases (HKCeND). The...
VISTA Eye Specialist Partners with PX Movement to Revolutionize Eye Care
PETALING JAYA, Malaysia, Dec. 6, 2024 /PRNewswire/ -- VISTA Eye Specialist (VISTA), Malaysia's leading provider of comprehensive eye care and refractive surgery services, proudly announces a transformative partnership with the PX Ninety program, led by world-renowned patient experience expert Shareef Mahdavi. This collaboration sets a new benchmark in healthcare excellence, aligning with VISTA's bold 2025 vision, Ikigai WowX (Wow...
Ono Enters into Drug Discovery Collaboration Agreement with Congruence Therapeutics to Generate Novel Small Molecule Correctors in the Oncology Area
OSAKA, Japan and MONTREAL , Dec. 6, 2024 /PRNewswire/ -- Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; "Ono") announced that it has entered into a drug discovery collaboration agreement with Congruence Therapeutics (Headquarters: Montreal, Quebec, Canada; CEO: Clarissa Desjardins; "Congruence") to generate novel small molecule correctors against multiple protein targets in the...
USANA Malaysia Named the Top Combination Dietary Supplements and Calcium Supplements Brand by Euromonitor International
KUALA LUMPUR, Malaysia, Dec. 6, 2024 /PRNewswire/ -- USANA Malaysia was recently awarded the title Top #1 Combination Dietary and Calcium Supplements Brand in Malaysia by market research giant Euromonitor International. This marks the sixth consecutive year the market received the combination dietary supplements honor and the first year in the calcium supplements...
IonOpticks’ Custom Chromatography Column to Become Biognosys’ Standard for High-Quality Proteomic Insights
MELBOURNE, Australia and ZURICH, Dec. 6, 2024 /PRNewswire/ -- Today, IonOpticks, a world leading provider of chromatography solutions, and Biognosys, a global leader in mass spectrometry-based proteomics contract research services, announce a long-term supply agreement. Under the agreement, IonOpticks will supply Biognosys with custom chromatography columns to support the standardisation of its research services platforms and enable deeper, reproducible proteome profiling....
Lunit and Volpara Unveiled Unified Ecosystem at RSNA 2024 to Transform Global Cancer Care
Lunit and Volpara revealed a unified Ecosystem at RSNA 2024, featuring AI-powered cancer risk prediction, autonomous report generation, and innovations to transform global cancer care SEOUL, South Korea, Dec. 5, 2024 /PRNewswire/ -- At this year's RSNA 2024 Annual Meeting, Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, and...
Neurophet to Participate in RSNA 2024: Unveiling Multiple Sclerosis Analysis Technology with Neurophet AQUA
Demonstrates MS Analysis Technology, Recently Secured FDA 510(k) Clearance Introduces 'Neurophet AQUA AD,' a Total Solution for Alzheimer's Disease Treatment Prescription, at the AI Theater SEOUL, South Korea, Dec. 5, 2024 /PRNewswire/ -- Neurophet, an artificial intelligence (AI) solution company for brain disease, announced its participation in the Radiological Society...
Prenetics’ IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services
Mission Launched via SpaceX CRS-31; Experiment Now Underway on the ISS Collaboration Aims to Enhance Healthspan on Earth and Improve Astronaut Health in Space IM8, a new premium supplements brand launched officially on November 18th on IM8health.com CHARLOTTE, N.C., Dec. 5, 2024 /PRNewswire/ -- Prenetics' IM8 is excited to announce that its groundbreaking month-long space experiment, in...
Field Medical’s FieldForce™ Ablation System Earns FDA TAP Pilot Acceptance and Breakthrough Device Designation for the Treatment of Ventricular Tachycardia.
First and only contact force pulsed field ablation (PFA) system engineered to revolutionize care for the hundreds of thousands at risk of death from ventricular tachycardia (VT). FDA's TAP Pilot and Breakthrough Device Designation are awarded to medical devices that could provide more effective treatment compared to existing approved treatments,...
